Safinamide Mesylate
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Safinamide Mesylate is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 21, 2017, and the first generic was approved Jun 14, 2023. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $8 million on Safinamide Mesylate across 4,385 claims for 759 beneficiaries.
Safinamide Mesylate is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $36.33 to $36.46 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$36.33 – $36.46
per EA
7d Activity
avg +0.1% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing SAFINAMIDE MESYLATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XADAGO 50 MG TABLET | $36.4591 per EA | — |
XADAGO 100 MG TABLET | $36.3258 per EA | +0.05% |
Frequently Asked Questions
What is Safinamide Mesylate used to treat?
Safinamide Mesylate is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
When did Safinamide Mesylate become available as a generic?
FDA approved the first generic Safinamide Mesylate (ANDA) on Jun 14, 2023. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Safinamide Mesylate?
In 2024, Medicare Part D spent $8 million on Safinamide Mesylate across 4,385 claims for 759 beneficiaries.
How many Safinamide Mesylate products are on the market?
The Safinamide Mesylate drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Safinamide Mesylate?
NADAC reference prices for Safinamide Mesylate range from $36.3258 to $36.4591 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Safinamide Mesylate?
1 manufacturer lists Safinamide Mesylate in NADAC. Ranked by number of NDCs, the largest are MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. (2).
How has the price of Safinamide Mesylate changed recently?
Over the past 7 days, 1 Safinamide Mesylate NDC rose and 0 fell, with a market-wide average change of +0.1%.